Jeffrey M. Venstrom, MD

Vanderbilt University, Vanderbilt School of Medicine, BS, 1995-1999, Neuroscience
Vanderbilt University, Vanderbilt School of Medicine, MD, 1999-2004, Medicine
National Institutes of Health, NIDDK, 2002-2003, Clinical Research
Johns Hopkins Hospital, Residency, 2004-2006, Internal Medicine
Memorial Sloan-Kettering Cancer Center, Fellowship, 2006-2010, Hematology/Oncology

• 2002-2003
  Research Fellow, National Institutes of Health, NIDDK, NIH Intramural Clinical Research Training Program
• 2004-2006
  Resident, Internal Medicine, Johns Hopkins Hospital. American Board of Internal Medicine Research Pathway - Internal Medicine Training
• 2006-2010
  Fellow, Medical Oncology and Hematology, Memorial Sloan-Kettering Cancer Center, American Board of Internal Medicine Research Pathway - Clinical Subspecialty and Research Training
• 2010-present
  Assistant Professor of Clinical Medicine, University of California, San Francisco

• 1998
  Phi Beta Kappa
• 1999
  Graduation with Honors, summa cum laude
• 2003
  Alpha Omega Alpha
• 2002
  Medical Student Fellow, NIH Intramural Clinical Research Training Program/Curriculum
• 2008
  Merit Award, American Society of Clinical Oncology
• 2008
  Cornell Clinical and Translational Science Center, Clinical Research Scholar Award

• Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, Petersdorf E, Hsu KC. Donor activating KIR3DS1 is associated with decreased acute GvHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood. Epub Feb 1, 2010.
• Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, Dupont B, O'Reilly RJ, Cheung N, Hsu KC. KIR and HLA Genotypes are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma. Clin Cancer Research 2009 Dec 1;15(23): 7330-7334 *Article highlighted in Nature Reviews Clin Oncol, Feb 2010
• Yu J, Venstrom J, Liu X, Hasan R, Pring J, O'Reilly R, Hsu K. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function following T-cell depleted allogeneic hematopoietic cell transplantation. Blood 2009 April 16;113(16):3875-84
• Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after Pancreas Transplantation in Patients with Diabetes and Preserved Kidney Function. JAMA 2003 Dec 3;290(21):2817-2823